A team of researchers with the UC Davis Comprehensive Cancer Center found that even with expanded access to Medi-Cal health coverage, Latino smokers in California continue to get less help than non-Latino white people quitting smoking.
Researchers at Fox Chase Cancer Center found that disparities in the incidence of head and neck cancer are driven by behavioral and environmental risk factors rather than race.
If 2020 was a year of reckoning, 2021 was a year of action—and major milestones for The Cancer Letter and the cancer community.
Wendy Brewster was named associate director of diversity, equity, and inclusion at UNC Lineberger Comprehensive Cancer Center.Â
Marshall Medical Center in Placerville, CA, and UC Davis Health have entered an affiliation for cancer services that allows Marshall patients access to the UC Davis Comprehensive Cancer Center through the UC Davis Health Cancer Care Network.Â
Black women experienced higher rates of breast cancer-related lymphedema than white women, and Black race was the strongest predictor of lymphedema development, according to results presented at the San Antonio Breast Cancer Symposium.
Every cancer center seeking to obtain (or keep) an NCI designation will soon have to present a plan for increasing the diversity of their faculty and workforce.
Christopher Li and Wendy Law, both of Fred Hutchinson Cancer Research Center, have a message for leaders of DEI programs in oncology.
Emergent public-private partnerships (PPPs) have risen to the occasion to streamline and coordinate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. With these monumental efforts have come important public discussions about equitable access and representation in clinical trials (CTs).
Bridget Oppong was named deputy director of the Center for Cancer Health Equity at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
